TECNALIA has signed a Framework Agreement for collaboration with GSK, a leading biopharmaceutical company in the research and development of medicines and vaccines, to participate in its initiative Gate2Health, an open innovation program that seeks to generate disruptive solutions to improve the lives of patients.
El Gate2Health program It is configured as a hub collaborative where startups, Technology companies, healthcare professionals, and patient associations are working together to identify challenges in the sector, share knowledge, and develop projects that transform care models. In this ecosystem, TECNALIA It will contribute its technological capacity, experience in applied research and strategic vision, consolidating its role as a European benchmark in innovation.
With over 1.500 professionals and a solid track record in areas such as healthTECNALIA will contribute to:
- Identifying needs and opportunities in the healthcare sector.
- Promote joint projects that address the identified challenges.
- Explore synergies and new avenues of collaboration to accelerate solutions with real impact.
Open Innovation
Gate2Health is an open innovation space in health that represents a new meeting point of reference between the protagonists of the innovation ecosystem of the sector, from health professionals and organizations and patients to entrepreneurs and entities of an academic, sports or technological nature, among others.
Within this framework, they seek to address the major challenges of the healthcare system in order to contribute to its sustainable transformation and improve patients' quality of life. Our objectives:
- Transforming technological research into prosperity.
- To be agents of transformation for companies and society, enabling them to adapt to the challenges of a constantly evolving future.
- To support high-impact projects to achieve effective transfer from R&D to the National Health System.
- A key player in ensuring that the client, and in this case the patient, are at the center, as one of the pillars of TECNALIA.
What will they achieve together?
- Focused innovation: we will focus on improving prevention in adults and transforming women's health.
- Solutions with real impact: we will promote scalable solutions, beyond the pilot, with key players in the health sector.
- Sustainable solutions over time: we will involve the Health System to ensure the future sustainability of the solutions implemented.
- Identifying new opportunities and challenges: we will create an interconnection space to explore new trends, generate shared lines of collaboration and welcome new opportunities.
This agreement reinforces our commitment to open innovation and the creation of strategic alliances that anticipate the future of health.
Challenges and areas of innovation
Gate2Health seeks to address various health challenges, such as disease prevention through vaccination and the transformation of women's health.
Together with GSK, TECNALIA It will work to launch initiatives that improve people's quality of life, from the development of advanced technologies to the exploration of new models of collaboration.